Dosage and Administration
Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

Two doses are required for primary immunization.

Annual revaccination with one dose is recommended.

Allow the vaccine to warm to room temperature prior to use.
Shake well before use.

Precautions

• Store between 2° and 7°C.  Do not freeze.
• Use new, non-chemically sterilized, needles and syringes.
• Do not mix with other vaccines.

Warnings

• Contains gentamicin and amphotericin B as preservatives.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.
  Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fiborsarcomas.
• It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain and adequate immune response following vaccination.  Prior exposure to the disease, or disease latency, are conditions in which vaccination testing of all cats for FeLV antigen prior to vaccination is recommended.  Also, vaccination with this product will not offer cross-protection against feline immunodeficiency virus (FIV), another feline retrovirus.  It is important to advise the cat owner of these situations prior to vaccination.